CRAIG T. SMITH, P.T.
Physical Therapy at North River Dr, Spokane, WA
License number
Washington PT00000708
Category
Restorative Service Providers
Type
Physical Therapist
Address
Address
2
322 NORTH North River Dr, Spokane, WA 99201
PO Box 34584, Seattle, WA 98124
PO Box 34584, Seattle, WA 98124
Phone
(509) 324-6464
(509) 241-7349
(509) 241-7628 (Fax)
(509) 241-7349
(509) 241-7628 (Fax)
Professional information
See more information about CRAIG T. SMITH at trustoria.com
Business Operations Manager At Safeco Insurance
Business Operations Manager At Safeco Insurance
Position:
Business Operations Manager at Safeco Insurance, Business Operations Manager at Liberty Mutual
Location:
Greater Seattle Area
Industry:
Insurance
Work:
Safeco Insurance
since Mar 1999
-
Business Operations Manager
Liberty Mutual
since 1999
-
Business Operations Manager
Gart Sports
1993 - 1999
-
Store Manager
Education:
Central Washington University 1980 - 1984
Bachelor of Science (B.S.), Business, Management, Marketing, and Related Support Services
Bachelor of Science (B.S.), Business, Management, Marketing, and Related Support Services
Skills:
Property & Casualty Insurance, Insurance, General Insurance, Underwriting, Process Improvement, Operations Management, Budgets
Craig Smith - Seattle, WA
Craig Smith - Seattle, WA
Work:
VolkerFitzpatrick
o Lead Quantity Surveyor Hadsphaltic International Limited
Senior Quantity Surveyor HBG Construction Limited
Project Quantity Surveyor Mansell Construction Services Ltd
Assistant QS John Laing Construction
o Lead Quantity Surveyor Hadsphaltic International Limited
Senior Quantity Surveyor HBG Construction Limited
Project Quantity Surveyor Mansell Construction Services Ltd
Assistant QS John Laing Construction
Education:
University of Wolverhampton
Bachelor of Science in Quantity Surveying
Bachelor of Science in Quantity Surveying
Information Technology And Services Professional
Information Technology And Services Professional
Location:
Greater Seattle Area
Industry:
Information Technology and Services
Immunomodulatory Compositions And Uses Therefor
Immunomodulatory Compositions And Uses Therefor
US Patent:
2009011, May 7, 2009
Filed:
Oct 6, 2008
Appl. No.:
12/246291
Inventors:
Craig A. Smith - Seattle WA, US
Steven Wiley - Seattle WA, US
Ajamete Kaykas - Seattle WA, US
Jalal Vakili - Seattle WA, US
Peter Probst - Seattle WA, US
Steven Wiley - Seattle WA, US
Ajamete Kaykas - Seattle WA, US
Jalal Vakili - Seattle WA, US
Peter Probst - Seattle WA, US
Assignee:
VIRAL LOGIC SYSTEMS TECHNOLOGY CORPORATION - SEATTLE WA
International Classification:
A61K 39/395, C07K 16/00, A61P 37/02
US Classification:
4241361, 5303891, 53038822, 5303873, 5303911, 4241301
Abstract:
The poxvirus proteins designated A41L and 130L bind to three receptor-like protein tyrosine phosphatases (RPTP), leukocyte common antigen related protein (LAR), RPTP-δ, and RPTP-σ, that are present on the cell surface of immune cells. When a host is infected with the poxvirus, binding of A41L to cell surface proteins on the host cells results in suppression of the immune response. The present invention provides agents such as antibodies, and antigen-binding fragments thereof, small molecules, aptamers, small interfering RNAs, and peptide-IgFc fusion polypeptides that interact with one or more of LAR, RPTP-δ, and RPTP-σ expressed by immune cells or interact with a polynucleotide encoding the RPTP. Also provided are RPTP Ig domain oligomers and Fc fusion polypeptides. Such agents are useful for treating an immunological disorder in a subject according to the methods described herein.
Dna Encoding Tumor Necrosis Factor-.Alpha. And -.Beta. Receptors
Dna Encoding Tumor Necrosis Factor-.Alpha. And -.Beta. Receptors
US Patent:
5395760, Mar 7, 1995
Filed:
May 10, 1990
Appl. No.:
7/523635
Inventors:
Craig A. Smith - Seattle WA
Raymond G. Goodwin - Seattle WA
M. Patricia Beckmann - Poulsbo WA
Raymond G. Goodwin - Seattle WA
M. Patricia Beckmann - Poulsbo WA
Assignee:
Immunex Corporation - Seattle WA
International Classification:
A61K 4505, C12P 2106, C12N 1500, C07H 1700
US Classification:
4352401
Abstract:
Tumor necrosis factor receptor proteins, DNAs and expression vectors encoding TNF receptors, and processes for producing TNF receptors as products of recombinant cell culture, are disclosed.
Cytokine Designated 4-Ibb Ligand
Cytokine Designated 4-Ibb Ligand
US Patent:
5674704, Oct 7, 1997
Filed:
May 6, 1994
Appl. No.:
8/236918
Inventors:
Raymond G. Goodwin - Seattle WA
Craig A. Smith - Seattle WA
Mark R. Alderson - Bainbridge Island WA
Craig A. Smith - Seattle WA
Mark R. Alderson - Bainbridge Island WA
Assignee:
Immunex Corporation - Seattle WA
International Classification:
C12N 1512, C12N 1563, C07K 14705
US Classification:
435 691
Abstract:
Novel 4-1BB ligand (4-1BB-L) polypeptides and a human cell surface receptor designated 4-1BB that binds 4-1BB-L are provided. Isolated 4-1BB-L-encoding and human 4-1BB-encoding DNA sequences, recombinant expression vectors comprising the isolated DNA sequences, and host cells transformed with the recombinant expression vectors are disclosed, along with methods for producing the novel polypeptides by cultivating such transformed host cells. Soluble forms of the 4-1BB-L or 4-1BB polypeptides are derived from the extracellular domains thereof.
Cd47 Related Compositions And Methods For Treating Immunological Diseases And Disorders
Cd47 Related Compositions And Methods For Treating Immunological Diseases And Disorders
US Patent:
8377448, Feb 19, 2013
Filed:
Jan 14, 2010
Appl. No.:
12/687334
Inventors:
Craig A. Smith - Seattle WA, US
Steven Wiley - Seattle WA, US
Ajamete Kaykas - Seattle WA, US
Peter Probst - Seattle WA, US
Steven Wiley - Seattle WA, US
Ajamete Kaykas - Seattle WA, US
Peter Probst - Seattle WA, US
Assignee:
The Board of Trustees of the Leland Standford Junior University - Palo Alto CA
International Classification:
A61K 39/00
US Classification:
4241851, 4241921, 530300, 530810
Abstract:
Provide herein are fusion polypeptides that comprise a CD47 extracellular domain or a variant thereof that is fused to a Fc polypeptide. The fusion polypeptides are useful for treating an immunological disease or disorder in a subject according to the methods described herein. The fusion polypeptides are capable of suppressing immunoresponsiveness of an immune cell, inhibiting production of proinflammatory cytokines, including inhibiting immune complex-induced production of cytokines.
Fusion Proteins Comprising Tumor Necrosis Factor Receptor
Fusion Proteins Comprising Tumor Necrosis Factor Receptor
US Patent:
2006027, Dec 7, 2006
Filed:
Jun 13, 2006
Appl. No.:
11/451450
Inventors:
Craig Smith - Seattle WA, US
International Classification:
A61K 38/17, C07H 21/04, C12P 21/06, C07K 14/715
US Classification:
435069100, 435320100, 435325000, 530350000, 514012000, 536023500
Abstract:
Fusion proteins having a tumor necrosis factor receptor (TNF-R) polypeptide and at least one additional polypeptide covalently fused thereto and selected from an interleukin-1 receptor (IL-1R) and a second TNF-R polypeptide. The receptor polypeptides are preferably fused together by a peptidyl linker. Suitable fusions include, for example, TNF-R-linker-TNF-R; TNF-R-linker-IL-1R; and TNF-R-linker-TNF-R-linker-IL-1R molecules.
Dna Sequences Encoding Granulocyte-Colony Stimulating Factor Receptors
Dna Sequences Encoding Granulocyte-Colony Stimulating Factor Receptors
US Patent:
5422248, Jun 6, 1995
Filed:
Jan 15, 1993
Appl. No.:
8/006183
Inventors:
Craig A. Smith - Seattle WA
Alf D. Larsen - Seattle WA
John E. Sims - Seattle WA
Benson M. Curtis - Seattle WA
Alf D. Larsen - Seattle WA
John E. Sims - Seattle WA
Benson M. Curtis - Seattle WA
Assignee:
Immunex Corporation - Seattle WA
International Classification:
C12N 1500, C12N 1511, C12N 1512
US Classification:
435 691
Abstract:
Mammalian granulocyte-colony stimulating factor (G-CSF) receptor proteins, DNAs and expression vectors encoding mammalian G-CSF receptors, and processes for producing mammalian G-CSF receptors as products of recombinant cell culture, are disclosed.
Methods For Treating Progressive Multiple Sclerosis
Methods For Treating Progressive Multiple Sclerosis
US Patent:
2012022, Sep 6, 2012
Filed:
Mar 7, 2012
Appl. No.:
13/414698
Inventors:
Craig Smith - Seattle WA, US
Peter S. Chin - San Francisco CA, US
Peter S. Chin - San Francisco CA, US
Assignee:
Genentech, Inc. - South San Francisco CA
International Classification:
A61K 39/395, A61P 25/00
US Classification:
4241351, 4241731, 4241331, 4241421
Abstract:
The present invention concerns methods for treating progressive multiple sclerosis (MS) in a patient, and an article of manufacture with instructions for such use.